WATCHMAN FLX LAAC Device

The WATCHMAN FLX™ left atrial appendage closure (LAAC) device is the first FDA-approved device indicated to reduce the risk of stroke in NVAF patients. Credit: Boston Scientific Corporation.



  • WATCHMAN FLX LAAC Device
  • WATCHMAN FLX LAAC Device
  • WATCHMAN FLX LAAC Device